Checkpoint Capital as of Dec. 31, 2024
Portfolio Holdings for Checkpoint Capital
Checkpoint Capital holds 16 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Argenx Se Sponsored Adr (ARGX) | 29.0 | $57M | 93k | 615.00 | |
| Rhythm Pharmaceuticals (RYTM) | 20.7 | $41M | 728k | 55.98 | |
| Phathom Pharmaceuticals (PHAT) | 9.4 | $19M | 2.3M | 8.12 | |
| Axsome Therapeutics (AXSM) | 7.5 | $15M | 175k | 84.61 | |
| Disc Medicine (IRON) | 6.0 | $12M | 185k | 63.40 | |
| Avadel Pharmaceuticals Com Shs (AVDL) | 5.4 | $11M | 1.0M | 10.51 | |
| Revolution Medicines (RVMD) | 4.7 | $9.2M | 210k | 43.74 | |
| Pliant Therapeutics (PLRX) | 3.6 | $7.1M | 536k | 13.17 | |
| Tscan Therapeutics (TCRX) | 2.7 | $5.3M | 1.8M | 3.04 | |
| Cidara Therapeutics Com New (CDTX) | 2.6 | $5.1M | 197k | 25.96 | |
| Trevi Therapeutics (TRVI) | 2.3 | $4.5M | 1.1M | 4.12 | |
| Stoke Therapeutics (STOK) | 1.7 | $3.4M | 305k | 11.03 | |
| Soleno Therapeutics (SLNO) | 1.6 | $3.1M | 70k | 44.95 | |
| Kymera Therapeutics (KYMR) | 1.6 | $3.1M | 78k | 40.23 | |
| Atyr Pharma Com New (ATYR) | 0.8 | $1.6M | 433k | 3.62 | |
| Cytokinetics Com New (CYTK) | 0.5 | $941k | 20k | 47.04 |
